Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb Study of F-1311 in Patients with Prostate Cancer
jRCT2080223135Phase 2Completed
- Sponsor
- PDRadiopharma Inc.
- Start
- Mar 2016
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of trofolastat in prostate adenocarcinoma, sponsored by PDRadiopharma Inc. Started Mar 2016; status: completed.
02
Drugs
trofolastat
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on jRCT2080223135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223135.